Integrating Metabolomics and Network Pharmacology to Explore the Protective Effect of Ginsenoside Re against Radiotherapy Injury in Mice

Table 3

Potential biomarker information.

No.	ESI mode	HMDBID	Metabolites	Chemical formula	VIP	RT (min)	m/z	Normal vs model trend	Model vs G-Re trend
1	−	HMDB0009156	PE (18 : 3 (9Z, 12Z, 15Z)/18 : 0)	C41H76NO8P	3.8777	1.954	740.50656	Up	Down
2	−	HMDB0008429	PC (20 : 4 (5Z, 8Z, 11Z, 14Z)/16 : 0)	C44H80NO8P	2.5692	8.974	826.57028	Down	Up
3	−	HMDB0001085	Leukotriene B4	C20H32O4	2.6425	3.290	671.46118	Up	Down
4	−	HMDB0003337	Oxidized glutathione	C20H32N6O12S2	1.4469	3.467	593.13535	Down	Up
5	−	HMDB0002710	Prostaglandin J2	C20H30O4	3.1346	3.247	379.21586	Down	—
6	−	HMDB0000673	Linoleic acid	C18H32O2	4.7441	12.039	279.21364	Down	Up
7	+	HMDB0010384	LysoPC (18 : 0)	C26H54NO7P	3.2924	6.363	524.37289	Up	Down
8	+	HMDB0010385	LysoPC (18 : 1 (11Z))	C26H52NO7P	1.3872	5.511	522.35657	Up	Down
9	+	HMDB0010383	LysoPC (16 : 1 (9Z))	C24H48NO7P	1.4353	4.513	494.32409	Up	Down
10	+	HMDB0007981	PC (16 : 0/20 : 3 (8Z, 11Z, 14Z))	C44H82NO8P	6.2389	6.158	806.60484	Down	Up
11	+	HMDB0012096	SM (d18 : 1/12 : 0)	C35H71N2O6P	1.1461	7.789	669.49175	Up	Down
12	+	HMDB0000220	Palmitic acid	C16H32O2	8.4544	3.243	274.27847	Up	Down
13	+	HMDB0004610	Phytosphingosine	C18H39NO3	4.6911	3.272	318.30280	Down	Up
14	+	HMDB0000638	Dodecanoic acid	C12H24O2	2.6015	2.273	218.21566	Down	–
15	+	HMDB0000269	Sphinganine	C18H39NO2	1.7346	3.805	302.30810	Down	Up
16	+	HMDB0000806	Myristic acid	C14H28O2	2.6476	2.773	246.24757	Down	Up